Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Nevanimibe HCl for the Treatment of Classic CAH
- Conditions
- Congenital Adrenal Hyperplasia
- Interventions
- First Posted Date
- 2018-09-13
- Last Posted Date
- 2021-03-04
- Lead Sponsor
- Millendo Therapeutics US, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT03669549
- Locations
- 🇧🇷
University of Ribeirão Preto, Medicine Faculty (Faculdade de Medicina) of Ribeirão Preto, Ribeirão Preto, Brazil
🇧🇷Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, Brazil
🇧🇷Hospital das Clínicas da FMUSP - Prédio do Instituto Central, São Paulo, Brazil
A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
- Conditions
- Cushing Syndrome
- Interventions
- Drug: ATR-101Drug: Placebo
- First Posted Date
- 2017-02-15
- Last Posted Date
- 2021-03-02
- Lead Sponsor
- Millendo Therapeutics US, Inc.
- Target Recruit Count
- 4
- Registration Number
- NCT03053271
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸The Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸Medical College of Wisconsin, Milwaukee, Wisconsin, United States
MLE4901 vs. Placebo for the Treatment of PCOS
- Conditions
- Polycystic Ovary Syndrome (PCOS)
- Interventions
- Drug: PlaceboDrug: MLE4901
- First Posted Date
- 2016-08-15
- Last Posted Date
- 2021-02-01
- Lead Sponsor
- Millendo Therapeutics US, Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT02865915
- Locations
- 🇺🇸
Hope Research Institute, LLC, Phoenix, Arizona, United States
🇺🇸NEA Baptist Clinic, Jonesboro, Arkansas, United States
🇺🇸Excell Research, Oceanside, California, United States